2 not yet recruiting. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Not yet recruiting 1 |
Follow Fertility-Sparing Treatment (FST): new trials by email Literature Review of Fertility-Sparing Treatment (FST) trials Research Report on Fertility-Sparing Treatment (FST)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Semaglutide, Weight Loss, and LNG-IUD for Conservative Treatment of Endometrial Atypical Hyperplasia and Grade 1 Endometrial Cancer Semaglutide (Wegovy) weekly injection, LNG-IUD (Progestin), Structured Weight Loss Program - Endometrial Atypical Hyperplasia, Endometrial Atypical Hyperplasia/Endometrioid Intraepithelial Neoplasia | Phase 2 | Not yet recruiting | The Methodist Hospital Research Institute | 48 | 2027-01-01 | 2026-10-01 |
| Ultrasound and Histology in AEH and Early EEC Treated Conservatively Hysteroscopic fertility-sparing surgery and hormonal treatment - Fertility-Sparing Treatment (FST), Atypical Endometrial Hyperplasia | Not yet recruiting | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | 50 | 2025-06-11 | 2025-06-19 |
Endometrial Hyperplasia (2) · Endometrial Neoplasms (2) · Obesity (1) · Overweight (1) · Weight Loss (1)
Female Urogenital Diseases (2) · Female Urogenital Diseases and Pregnancy Complications (2) · Genital Diseases (2) · Genital Diseases, Female (2) · Genital Neoplasms, Female (2) · Neoplasms (2) · Neoplasms by Site (2) · Urogenital Diseases (2) · Urogenital Neoplasms (2) · Uterine Diseases (2) · Uterine Neoplasms (2) · Body Weight (1) · Body Weight Changes (1) · Nutrition Disorders (1) · Nutritional and Metabolic Diseases (1)
Intrauterine Devices (1) · semaglutide (1)
Fondazione Policlinico Universitario Agostino Gemelli IRCCS (1) · The Methodist Hospital Research Institute (1)
Italy (1) · United States (1)
Antonia Carla Testa (1) · Aparna A. Kamat, MD (1)